COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Validation of Sexual Function Scale in Female Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01809405
Recruitment Status : Unknown
Verified March 2014 by Sang-Yoon Park, National Cancer Center, Korea.
Recruitment status was:  Recruiting
First Posted : March 12, 2013
Last Update Posted : March 20, 2014
Information provided by (Responsible Party):
Sang-Yoon Park, National Cancer Center, Korea

Brief Summary:
To validate the FSFI(Female Sexual Function Index)-K, FSFI - 6 item and Quality of Sexual Function(QSF) version in Korean language of the cancer patients.

Condition or disease
Sexuality Cancer Healthy Women

Detailed Description:

Due to the observational nature of the study which aims to evaluate the internal consistency and validity of the Korean version of Questionnaire, formal sample size and power calculations were not performed. When the number of observations (items) per subject ranges from 4 to 6, roughly 152-199 patients are required to show 10% increase in intraclass correlation from baseline ICC of 30% with 85% power and 5% type I error rate. The sample size was determined based on this calculation and practical considerations.

The pilot study will be performed based on 30 people (include reference), and the main study will include 1100 people (considering 10% drop-out from 200 people in each group) cancer type (ovary, cervix, endometrium, and breast) and healthy female. Total 1130 patients.

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 1130 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 3 Weeks
Study Start Date : December 2012
Actual Primary Completion Date : February 2014
Estimated Study Completion Date : December 2016

Primary Outcome Measures :
  1. sexuality [ Time Frame: 2-4 weeks ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
About 1130 adult women living in Korea

Inclusion Criteria:

  • Healthy women

    • Female without history of cancer
    • Cancer free as of the most recent linkage
    • At least 18 years of age
    • Able to speak and read Korean
    • Sexual activity within 3months.
  • Female cancer patient

    • History of gynecological or breast cancer
    • At least 18 years of age
    • Able to speak and read Korean
    • Sexual activity within 3months.

Exclusion Criteria:

  • Women who are unable to complete the questionnaires.
  • Refuse to participate in the survey.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01809405

Layout table for location contacts
Contact: Sang-Yoon Park
Contact: Myong Cheol Lim

Layout table for location information
Korea, Republic of
National Cancer Center Recruiting
Goyang, Gyeonggi-do, Korea, Republic of
Contact: irb   
Principal Investigator: Sang-Yoon Park         
Sponsors and Collaborators
National Cancer Center, Korea
Additional Information:

Layout table for additonal information
Responsible Party: Sang-Yoon Park, Senior researcher, National Cancer Center, Korea Identifier: NCT01809405    
Other Study ID Numbers: NCCNCS-12-685
First Posted: March 12, 2013    Key Record Dates
Last Update Posted: March 20, 2014
Last Verified: March 2014